Curbo, Danny .
HRN: 25-94-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/24/2024
10/01/2024
IV
4.5g
Q8h
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes